- Home
- XP vs HSIC Comparison
XP vs HSIC Comparison
Compare XP & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XP | HSIC |
|---|---|---|
| Founded | 2001 | 1932 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 8.8B |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XP | HSIC |
|---|---|---|
| Price | $16.41 | $76.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $22.80 | ★ $76.50 |
| AVG Volume (30 Days) | ★ 7.2M | 1.2M |
| Earning Date | 11-17-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | 18.53 | ★ 30.70 |
| EPS | 1.76 | ★ 3.17 |
| Revenue | $3,229,174,949.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $17.10 | $5.35 |
| Revenue Next Year | $12.69 | $3.34 |
| P/E Ratio | ★ $9.29 | $24.14 |
| Revenue Growth | ★ 8.33 | 3.51 |
| 52 Week Low | $10.82 | $60.56 |
| 52 Week High | $20.64 | $82.49 |
Technical Indicators
Market Signals| Indicator | XP | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 58.76 |
| Support Level | $15.85 | $76.27 |
| Resistance Level | $16.53 | $78.10 |
| Average True Range (ATR) | 0.63 | 1.31 |
| MACD | -0.18 | -0.14 |
| Stochastic Oscillator | 18.26 | 64.50 |
Price Performance
Historical ComparisonAbout XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.